COVID-19, Adrenal Insufficiency, Adrenal Hyperfunction
Conditions
Keywords
SARS-CoV-2 infection, Adrenal Cortex, Salivary Cortisol, Salivary DHEA, Aldosterone, ACTH, Interleukin 6, Circadian Rythm
Brief summary
In the year of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic several studies have focused on the effect of the COVID-19 on the adrenal cortex, demonstrating conflicting results. Herein, researchers sought to investigate the adrenal response in patients with COVID-19by assessing the diurnal rhythm of salivary cortisol and the adrenal androgen dehydroepiandrosterone (DHEA), as well as the plasma levels of aldosterone and adrenocorticotropic hormone (ACTH) in consecutive patients before the possible therapeutic administration of dexamethasone. To elucidate the potential association between the magnitude of individual immune response and the adrenal cortex response we included serum measurements of interleukin - 6 (IL-6).
Detailed description
All adult consecutive patients that visited the emergency department of the LAIKO General Hospital of Athens from May to July 2021 due to confirmed COVID-19 and related symptomatology were eligible for the study. Age and gender matched healthy individuals without COVID-19 who had never been treated with GCs and fulfilled the exclusion criteria were also recruited from the Hospital's personnel and included in the analysis as Controls. Blood samples were obtained immediately upon admission for the measurements of ACTH, IL-6 and aldosterone, which were performed by electrochemiluminescence assays on the cobas e 801 immunoassay analysers (Roche Diagnostics GmbH). Salivary samples for free cortisol and DHEAS were obtained during the next day using the Salivette (Sarstedt, Nümbrecht, Germany) at different time points 0800, 12.00, 18.00, and 22.00. Within 24h after saliva collection the salivettes were centrifuged at 2400 g for 20 min in 4 °C and aliquots were stored at -80 °C and analyzed by an Immunochemiluminescence assay in a Roche COBAS E411 analyzer.
Interventions
Assessment of circulating levels of plasma ACTH, plasma aldosterone and serum interleukin -6 levels at day 1
Assessment of diurnal variation of cortisol and DHEA levels in the saliva at 4 different time points during the day (0.800, 12.00, 18.00, 22.00) at day 2.
Sponsors
Study design
Eligibility
Inclusion criteria
Adult patients that visited the Emergency Department of LAIKO General Hospital of Athens, Greece from May to July 2021 due to confirmed COVID-19 and related symptomatology
Exclusion criteria
(i) pre-existing hypoadrenalism or concurrent systemic glucocorticoid treatment (ii) patients with chronic kidney disease stage 3b and above, (iii) patients with advanced metastatic disease.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Diurnal variation of cortisol levels in the saliva (mcg/dL) | One day | Saliva sampling was performed at 4 different time points during one day (08.00, 12.00, 18.00, 22.00). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Single hormone assessment of plasma ACTH levels (pg/mL) | One day | Blood sampling was performed on the day of Hospital admission at one time point |
| Diurnal variation of dehydroepiandrosterone (DHEA) levels (pg/mL) in the saliva | One day | Saliva sampling was performed at 4 different time points during one day (08.00, 12.00, 18.00, 22.00). |
| Single hormone assessment of plasma aldosterone levels (pmol/L) | One day | Blood sampling was performed on the day of Hospital admission at one time point |
| Single hormone assessment of serum Interleukin-6 levels (IL-6) (pg/mL) | One day | Blood sampling was performed on the day of Hospital admission at one time point |
| Single hormone assessment of serum C-reactive protein levels (CRP) (mg/L) | One Day | Blood sampling was performed on the day of Hospital admission at one time point |
Countries
Greece